DF/HCC Prostate Cancer SPORE RFP

April 01, 2019

The DF/HCC Prostate Cancer Program seeks research project proposals for potential inclusion in a 5-year Specialized Program on Research Excellence (SPORE) grant.

Applicants must be faculty at Harvard Medical School at the level of Assistant Professor or higher. The proposed research can be basic or clinical, but bench-to-bedside and bedside-to-bench strategies need to be addressed, since the purpose of this program is to promote translational research in prostate cancer. All basic research supported by the SPORE must have a plan for translation into application or studies in humans within the 5 years of  grant proposal. In order to facilitate this translation, projects should be co-led by a basic and a clinically oriented scientist.

We are seeking pre-applications in the form of a 1-2-page proposal that includes background, specific aims, research plan, and plan for translation. These pre-applications will be judged on their scientific merit, translational potential, relevance to prostate cancer, qualifications of the research team and the potential fit within the overall activities of the DF/HCC Prostate Cancer Program and SPORE. Based on these pre-applications, we anticipate inviting up to ~10-12 investigators to further develop their proposals for presentation at a project review meeting, with final project selections being made by a panel including members of the Prostate Cancer Program and SPORE Governance Committee and Internal Advisory Board. Ultimately, 3-5 projects will be included in the final SPORE application. If the SPORE grant is funded, we anticipate that the project awards will be granted at a level of approximately $150,000 in yearly direct costs for 5 years. The awardees will become members of DF/HCC Prostate Cancer Program and SPORE and would be expected to attend SPORE activities (meetings, retreats, research presentations). Women and minority candidates are strongly encouraged to apply.

Inquiries regarding whether potential projects may be suitable are welcomed. Program directors (Steven Balk or Himisha Beltran) would be happy to assist investigators in identification of potential clinical or basic collaborators, or in exploring how available core resources may be used to advance translational goals.

Please submit proposals in PDF format by Monday, April 15, 2019 to:

Joan Coraccio (JoanA_Coraccio@DFCI.HARVARD.EDU)

With copies to:
Himisha Beltran (Himisha_Beltran@ DFCI.HARVARD.EDU
Steven Balk (sbalk@bidmc.harvard.edu)